Saturday 17 October 2026
Export MDRX’s income statement to Excel — free account
Veradigm Inc.
MDRX Healthcare Health Information Services
5.00
0.00
0.00%
Follow MDRX
| Older periods | Mar '22 | Jun '22 | Sep '22 | Dec '22 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
10.12% | 5.21% | 5.07% | (7.27%) | |
Piotroski F-Score |
4 | 7 | — | 7 | |
| 5.79% | 3.17% | 3.15% | (4.53%) | ||
ROIC |
2.87% | 3.73% | 4.24% | (2.20%) | |
Return on Tangible Assets |
16.98% | 11.48% | 11.55% | (18.85%) | |
Average Days of Receivables |
106.12 | 102.09 | 102.25 | 73.96 | |
Free Cash Flow per Share |
(0.47) | 1.25 | 1.07 | 0.75 | |
Free Cash Flow |
(54.89) | 143.04 | 117.80 | 84.56 | |
Capital Expenditures |
(42.96) | (44.33) | (41.82) | (32.27) | |
| Other line items | |||||
Cash ROIC |
(3.03%) | 7.54% | 6.30% | 5.08% | |
Accounts Receivable Turnover |
2.11 | 2.36 | 2.37 | 4.92 | |
Accounts Payable Turnover |
13.83 | 13.04 | 16.60 | 16.94 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
19.34 | 22.51 | 16.12 | 40.26 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.09) | (0.01) | (0.07) | (0.70) | |
Research and Development Expense of Revenue |
14.81% | 14.87% | 15.13% | 16.65% | |
Selling, General and Administrative Expense of Revenue |
20.62% | 25.60% | 26.15% | 28.77% | |
Share Based Compensation of Revenue |
2.61% | 3.75% | 3.80% | 4.27% | |
Interest Coverage |
3.13 | 2.43 | 3.47 | (4.27) | |
Operating CF/Net income |
(0.08) | 2.78 | 2.43 | (1.35) | |
Depreciation/Fixed assets |
7.59 | 4.56 | 5.64 | 11.15 | |
Capex/Depreciation |
(0.61) | (0.65) | (0.63) | (0.31) | |
Revenue per Share |
5.06 | 5.22 | 5.48 | 5.25 | |
Operating CF per Share |
(0.10) | 1.64 | 1.45 | 1.04 | |
Capex per Share |
(0.37) | (0.39) | (0.38) | (0.29) | |
Capex to Sales |
0.07 | 0.07 | 0.07 | 0.05 |
Columns are period end dates · fundamentals updated 1 Oct 2026